Suppr超能文献

人源化抗 DNAIIbFab 片段联合氧氟沙星清除实验性中耳炎生物膜。

Humanized Anti-DNABII Fab Fragments Plus Ofloxacin Eradicated Biofilms in Experimental Otitis Media.

机构信息

Center for Microbial Pathogenesis, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, U.S.A.

The Ohio State University College of Medicine, Columbus, Ohio, U.S.A.

出版信息

Laryngoscope. 2021 Oct;131(10):E2698-E2704. doi: 10.1002/lary.29497. Epub 2021 Mar 5.

Abstract

OBJECTIVES/HYPOTHESIS: To evaluate the ability of humanized monoclonal antibody fragments directed against a bacterial DNABII protein plus ofloxacin delivered directly into the chinchilla middle ear via tympanostomy tube (TT) to enhance the ability of ofloxacin to eradicate biofilms formed by nontypeable Haemophilus influenzae (NTHI).

STUDY DESIGN

A blinded pre-clinical study of comparative efficacy of single versus combinatorial treatment strategies.

METHODS

NTHI was allowed to form biofilms in the middle ears of chinchillas prior to TT placement. Ofloxacin, humanized Fab fragments against a bacterial DNABII protein that disrupts biofilms or Fab fragments plus ofloxacin were instilled into the middle ear via TT. For two consecutive days, ofloxacin was delivered twice-a-day, Fab fragments were delivered once-a-day, or these treatments were combined. Relative biofilm resolution (as determined via two outcome measures) and eradication of viable NTHI were assessed 1-day later.

RESULTS

Whereas ofloxacin alone did not resolve biofilms or eradicate NTHI from the middle ear, delivery of Fab fragments significantly reduced both biofilms and NTHI burden over this short course of treatment. Notably, co-delivery of ofloxacin plus humanized Fab fragments eradicated both NTHI and biofilms from the middle ear, an enhanced outcome compared to receipt of either treatment alone.

CONCLUSION

This study demonstrated a powerful combinatorial approach to release bacteria from their protective biofilms and rapidly render them vulnerable to killing by a previously ineffective antibiotic. An approach to combine ofloxacin with humanized Fab fragments that disrupt biofilms has tremendous potential to quickly resolve chronic otorrhea suffered by children with chronic suppurative otitis media or chronic post-tympanostomy tube otorrhea and thereby improve their quality of life.

LEVEL OF EVIDENCE

NA Laryngoscope, 131:E2698-E2704, 2021.

摘要

目的/假设:评估针对细菌 DNAII 蛋白的人源化单克隆抗体片段与氧氟沙星联合应用,通过鼓室置管(TT)直接递送至南美栗鼠中耳,以增强氧氟沙星根除由非典型流感嗜血杆菌(NTHI)形成的生物膜的能力。

研究设计

一项关于单药与联合治疗策略比较疗效的盲法临床前研究。

方法

在 TT 放置之前,允许 NTHI 在南美栗鼠的中耳中形成生物膜。通过 TT 将氧氟沙星、针对破坏生物膜的细菌 DNAII 蛋白的人源化 Fab 片段或 Fab 片段加氧氟沙星递送至中耳。连续两天,每天两次给予氧氟沙星,每天一次给予 Fab 片段,或联合应用这些药物。1 天后通过两种结局指标评估相对生物膜清除率(作为确定结果的依据)和活 NTHI 的根除情况。

结果

虽然单独使用氧氟沙星不能清除生物膜或从中耳中根除 NTHI,但在这个短疗程的治疗中,给予 Fab 片段可显著降低生物膜和 NTHI 负担。值得注意的是,与单独接受任何一种治疗相比,联合给予氧氟沙星和人源化 Fab 片段可从中耳中根除 NTHI 和生物膜,这是一种增强的治疗结果。

结论

这项研究展示了一种强大的联合方法,可以使细菌从其保护性生物膜中释放出来,并迅速使其对先前无效的抗生素变得敏感。将氧氟沙星与破坏生物膜的人源化 Fab 片段联合应用的方法具有很大的潜力,可以迅速缓解慢性化脓性中耳炎或慢性鼓室置管后耳漏患儿所遭受的慢性耳溢液,并因此改善他们的生活质量。

证据水平

无 Laryngoscope, 131:E2698-E2704, 2021.

相似文献

5
Direct evidence of bacterial biofilms in otitis media.中耳炎中细菌生物膜的直接证据。
Laryngoscope. 2001 Dec;111(12):2083-94. doi: 10.1097/00005537-200112000-00001.

引用本文的文献

3
Fluoroquinolones and Biofilm: A Narrative Review.氟喹诺酮类药物与生物膜:一篇叙述性综述。
Pharmaceuticals (Basel). 2024 Dec 11;17(12):1673. doi: 10.3390/ph17121673.

本文引用的文献

4
Role of Biofilms in Post-Tympanostomy Tube Otorrhea.生物膜在鼓室成形术后耳漏中的作用。
Ear Nose Throat J. 2020 Nov;99(1_suppl):22S-29S. doi: 10.1177/0145561320914437. Epub 2020 Mar 24.
6
Topical antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗生素
Cochrane Database Syst Rev. 2020 Jan 2;1(1):CD013051. doi: 10.1002/14651858.CD013051.pub2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验